Editas Medicine Inc (EDIT)
2.77
-0.19
(-6.42%)
USD |
NASDAQ |
Nov 14, 16:00
2.80
+0.03
(+1.08%)
After-Hours: 20:00
Editas Medicine Total Return Level: 2.77 for Nov. 14, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 14, 2024 | 2.77 |
November 13, 2024 | 2.96 |
November 12, 2024 | 3.07 |
November 11, 2024 | 3.30 |
November 08, 2024 | 3.12 |
November 07, 2024 | 3.17 |
November 06, 2024 | 3.28 |
November 05, 2024 | 3.12 |
November 04, 2024 | 2.88 |
November 01, 2024 | 2.91 |
October 31, 2024 | 2.90 |
October 30, 2024 | 3.02 |
October 29, 2024 | 3.11 |
October 28, 2024 | 3.26 |
October 25, 2024 | 3.18 |
October 24, 2024 | 3.18 |
October 23, 2024 | 3.21 |
October 22, 2024 | 3.29 |
October 21, 2024 | 3.76 |
October 18, 2024 | 3.36 |
October 17, 2024 | 3.31 |
October 16, 2024 | 3.45 |
October 15, 2024 | 3.36 |
October 14, 2024 | 3.24 |
October 11, 2024 | 3.19 |
Date | Value |
---|---|
October 10, 2024 | 2.96 |
October 09, 2024 | 3.12 |
October 08, 2024 | 3.17 |
October 07, 2024 | 3.21 |
October 04, 2024 | 3.38 |
October 03, 2024 | 3.20 |
October 02, 2024 | 3.22 |
October 01, 2024 | 3.27 |
September 30, 2024 | 3.41 |
September 27, 2024 | 3.48 |
September 26, 2024 | 3.49 |
September 25, 2024 | 3.39 |
September 24, 2024 | 3.53 |
September 23, 2024 | 3.66 |
September 20, 2024 | 3.77 |
September 19, 2024 | 3.91 |
September 18, 2024 | 3.88 |
September 17, 2024 | 3.86 |
September 16, 2024 | 3.83 |
September 13, 2024 | 3.95 |
September 12, 2024 | 3.75 |
September 11, 2024 | 3.78 |
September 10, 2024 | 3.77 |
September 09, 2024 | 3.51 |
September 06, 2024 | 3.59 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
2.77
Minimum
Nov 14 2024
90.58
Maximum
Jan 08 2021
21.82
Average
15.84
Median
Total Return Level Benchmarks
EyePoint Pharmaceuticals Inc | 10.49 |
Cassava Sciences Inc | 44.19 |
Adverum Biotechnologies Inc | 7.25 |
Regenxbio Inc | 11.14 |
Apellis Pharmaceuticals Inc | 28.06 |